Medicine Shortage UK 2026 — Complete List

Class 1 Medicines Recall Notification: Recall of Quetiapine Oral Suspension (unlicensed medicine), manufactured by Eaststone Limited due to a potentia...

Eaststone Limited is initiating a recall of all batches of quetiapine oral suspension products due to a potential risk of overdose, which could have consequences for the safety of patients.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Class 1 Medicines Recall Notification: Recall of Quetiapine Oral Suspension (unlicensed medicine), manufactured by Eaststone Limited due to a potentia...

Eaststone Limited is initiating a recall of all batches of quetiapine oral suspension products due to a potential risk of overdose, which could have consequences for the safety of patients.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Mounjaro KwikPen 15mg pre-filled pens

A falsified version of Mounjaro (tirzepatide) KwikPen 15mg solution for injection has been found supplied through one online pharmacy in the UK. The falsified product is labelled with batch D873576 an

Finasteride: reminder of the risk psychiatric side effects and of sexual side effects

A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfuncti

Antimicrobial Agents Used in Tuberculosis (TB) Treatment

This National Patient Safety Alert has been superseded by Medicine Supply Notification MSN/2025/058 Antimicrobial Agents Used in Tuberculosis (TB) Treatment issued on 23 October 2025 • Rifampicin 150m

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Diamorphine 5mg, 10mg and 100mg powder for solution for injection ampoules

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Diamorphine 5mg, 10mg and 100mg powder for solution for injection ampoules. • Diamorphine 5 mg and 10 mg powde

Estradot® 25 microgram patches

Serious Shortage Protocol active for Estradot® 25 microgram patches (PDF:218KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estradot® 100 microgram patches

Serious Shortage Protocol active for Estradot® 100 microgram patches (PDF:215KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estradot® 75 microgram patches

Serious Shortage Protocol active for Estradot® 75 microgram patches (PDF:219KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estradot® 50 microgram patches

Serious Shortage Protocol active for Estradot® 50 microgram patches (PDF:219KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Creon® 25000 capsules

Serious Shortage Protocol active for Creon® 25000 capsules (PDF:193KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Creon® 10000 capsules

Serious Shortage Protocol active for Creon® 10000 capsules (PDF:193KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Latanoprost 50micrograms/ml / Timolol 5mg/ml (Fixapost®) eye drops 0.2ml unit dose preservative free

Serious Shortage Protocol active for Latanoprost 50micrograms/ml / Timolol 5mg/ml (Fixapost®) eye drops 0.2ml unit dose preservative free (PDF:193KB). Pharmacists may supply alternatives without GP re

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Adipine® XL 60mg MR tablets

Serious Shortage Protocol active for Adipine® XL 60mg MR tablets (PDF:199KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Venlafaxine 37.5mg modified release tablet

Serious Shortage Protocol active for Venlafaxine 37.5mg modified release tablet (PDF:156KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Cefalexin 250mg/5ml oral suspension sugar free

Serious Shortage Protocol active for Cefalexin 250mg/5ml oral suspension sugar free (PDF:143KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Cefalexin 125mg/5ml oral suspension sugar free

Serious Shortage Protocol active for Cefalexin 125mg/5ml oral suspension sugar free (PDF:143KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Nyzamac® SR 60mg capsules

Serious Shortage Protocol active for Nyzamac® SR 60mg capsules (PDF:162KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Monomil® XL 60mg tablets

Serious Shortage Protocol active for Monomil® XL 60mg tablets (PDF:162KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Monomax® XL 60mg tablets

Serious Shortage Protocol active for Monomax® XL 60mg tablets (PDF:162KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Chemydur® 60XL tablets

Serious Shortage Protocol active for Chemydur® 60XL tablets (PDF:163KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Cefalexin 500mg tablets

Serious Shortage Protocol active for Cefalexin 500mg tablets (PDF:138KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Ramipril 2.5mg tablets

Serious Shortage Protocol active for Ramipril 2.5mg tablets (PDF:139KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Quetiapine 300mg tablets substitution and restriction

Serious Shortage Protocol active for Quetiapine 300mg tablets substitution and restriction (PDF:201KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Quetiapine 300mg tablets restriction

Serious Shortage Protocol active for Quetiapine 300mg tablets restriction (PDF:202KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Quetiapine 300mg tablets substitution

Serious Shortage Protocol active for Quetiapine 300mg tablets substitution (PDF:204KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Quetiapine 200mg tablets substitution and restriction

Serious Shortage Protocol active for Quetiapine 200mg tablets substitution and restriction (PDF:203KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Quetiapine 200mg tablets restriction

Serious Shortage Protocol active for Quetiapine 200mg tablets restriction (PDF:202KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Quetiapine 200mg tablets substitution

Serious Shortage Protocol active for Quetiapine 200mg tablets substitution (PDF:205KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Quetiapine 150mg tablets substitution and restriction

Serious Shortage Protocol active for Quetiapine 150mg tablets substitution and restriction (PDF:204KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Quetiapine 150mg tablets restriction

Serious Shortage Protocol active for Quetiapine 150mg tablets restriction (PDF:203KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Quetiapine 150mg tablets substitution

Serious Shortage Protocol active for Quetiapine 150mg tablets substitution (PDF:205KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Monomil® XL 60mg tablets

Serious Shortage Protocol active for Monomil® XL 60mg tablets (PDF:164KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Jext® 300micrograms/0.3ml (1 in 1000) solution for injection auto-injector pen

Serious Shortage Protocol active for Jext® 300micrograms/0.3ml (1 in 1000) solution for injection auto-injector pen (PDF:200KB). Pharmacists may supply alternatives without GP referral.

Expected resolution: 1 in 1000

Estradot® 100mcg patches

Serious Shortage Protocol active for Estradot® 100mcg patches (PDF:218KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Utrogestan® 100mg capsules

Serious Shortage Protocol active for Utrogestan® 100mg capsules (PDF:193KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estradot® 75mcg patches

Serious Shortage Protocol active for Estradot® 75mcg patches (PDF:216KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Clarithromycin 250mg/5ml oral suspension

Serious Shortage Protocol active for Clarithromycin 250mg/5ml oral suspension (PDF:150KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Clarithromycin 125mg/5ml oral suspension

Serious Shortage Protocol active for Clarithromycin 125mg/5ml oral suspension (PDF:147KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Progynova® TS 100mcg patches

Serious Shortage Protocol active for Progynova® TS 100mcg patches (PDF:217KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Paracetamol 240mg suppositories

Serious Shortage Protocol active for Paracetamol 240mg suppositories (PDF:142KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Paracetamol 120mg suppositories

Serious Shortage Protocol active for Paracetamol 120mg suppositories (PDF:143KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estradot® 100mcg patches

Serious Shortage Protocol active for Estradot® 100mcg patches (PDF:205KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estradot® 50mcg patches

Serious Shortage Protocol active for Estradot® 50mcg patches (PDF:205KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Phenoxymethylpenicillin 250mg tablets

Serious Shortage Protocol active for Phenoxymethylpenicillin 250mg tablets (PDF:272KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Phenoxymethylpenicillin 250mg/5ml oral solution sugar free

Serious Shortage Protocol active for Phenoxymethylpenicillin 250mg/5ml oral solution sugar free (PDF:274KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Phenoxymethylpenicillin 250mg/5ml oral solution

Serious Shortage Protocol active for Phenoxymethylpenicillin 250mg/5ml oral solution (PDF:274KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Phenoxymethylpenicillin 125mg/5ml oral solution sugar free

Serious Shortage Protocol active for Phenoxymethylpenicillin 125mg/5ml oral solution sugar free (PDF:275KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Phenoxymethylpenicillin 125mg/5ml oral solution

Serious Shortage Protocol active for Phenoxymethylpenicillin 125mg/5ml oral solution (PDF:273KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Phenoxymethylpenicillin 250mg/5ml oral solution

Serious Shortage Protocol active for Phenoxymethylpenicillin 250mg/5ml oral solution (PDF:143KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Phenoxymethylpenicillin 250mg/5ml oral solution sugar free

Serious Shortage Protocol active for Phenoxymethylpenicillin 250mg/5ml oral solution sugar free (PDF:145KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Phenoxymethylpenicillin 125mg/5ml oral solution sugar free

Serious Shortage Protocol active for Phenoxymethylpenicillin 125mg/5ml oral solution sugar free (PDF:138KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

atorvastatin (Lipitor®)20mg chewable tablets

Serious Shortage Protocol active for atorvastatin (Lipitor®)20mg chewable tablets (PDF:150KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estraderm MX® 75mcg patches substitution

Serious Shortage Protocol active for Estraderm MX® 75mcg patches substitution (PDF:214KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estraderm MX® 50mcg patches substitution

Serious Shortage Protocol active for Estraderm MX® 50mcg patches substitution (PDF:214KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estraderm MX® 100mcg patches

Serious Shortage Protocol active for Estraderm MX® 100mcg patches (PDF:214KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estraderm MX® 25mcg patches

Serious Shortage Protocol active for Estraderm MX® 25mcg patches (PDF:213KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Combisal® 125mcg/25mcg inhalers

Serious Shortage Protocol active for Combisal® 125mcg/25mcg inhalers (PDF:146KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Paracetamol 120mg suppositories

Serious Shortage Protocol active for Paracetamol 120mg suppositories (PDF:139KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Atorvastatin (Lipitor®) 10mg chewable tablets

Serious Shortage Protocol active for Atorvastatin (Lipitor®) 10mg chewable tablets (PDF:145KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estradiol (Sandrena®) 0.5mg and 1mg gel sachets substitution and restriction

Serious Shortage Protocol active for Estradiol (Sandrena®) 0.5mg and 1mg gel sachets substitution and restriction (PDF:751KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estradiol (Sandrena®) 0.5mg and 1mg gel sachets substitution

Serious Shortage Protocol active for Estradiol (Sandrena®) 0.5mg and 1mg gel sachets substitution (PDF:751KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estradiol (Sandrena®) 0.5mg and 1mg gel sachets restriction

Serious Shortage Protocol active for Estradiol (Sandrena®) 0.5mg and 1mg gel sachets restriction (PDF:600KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estradiol (Lenzetto®)1.53mg/dose transdermal spray substitution and restriction

Serious Shortage Protocol active for Estradiol (Lenzetto®)1.53mg/dose transdermal spray substitution and restriction (PDF:749KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estradiol (Lenzetto®)1.53mg/dose transdermal spray substitution

Serious Shortage Protocol active for Estradiol (Lenzetto®)1.53mg/dose transdermal spray substitution (PDF:748KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estradiol (Lenzetto®)1.53mg/dose transdermal spray restriction

Serious Shortage Protocol active for Estradiol (Lenzetto®)1.53mg/dose transdermal spray restriction (PDF:601KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estriol (Ovestin® 1mg cream) 0.1% cream substitution and restriction

Serious Shortage Protocol active for Estriol  (Ovestin® 1mg cream) 0.1% cream substitution and restriction (PDF:228KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estriol (Ovestin® 1mg cream) 0.1% cream substitution

Serious Shortage Protocol active for Estriol  (Ovestin® 1mg cream) 0.1% cream substitution (PDF:226KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estradiol (Oestrogel® Pump-Pack 0.06% gel) 0.06% gel (750microgram per actuation) substitution and restriction

Serious Shortage Protocol active for Estradiol (Oestrogel® Pump-Pack 0.06% gel) 0.06% gel (750microgram per actuation) substitution and restriction (PDF:751KB). Pharmacists may supply alternatives wit

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estradiol (Oestrogel® Pump-Pack 0.06% gel) 0.06% gel (750microgram per actuation) substitution

Serious Shortage Protocol active for Estradiol (Oestrogel® Pump-Pack 0.06% gel) 0.06% gel (750microgram per actuation) substitution (PDF:750KB). Pharmacists may supply alternatives without GP referral

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Premique® low dose 0.3mg/1.5mg modified-release tablets

Serious Shortage Protocol active for Premique® low dose 0.3mg/1.5mg modified-release tablets (PDF:166KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Ovestin® 1mg cream restriction

Serious Shortage Protocol active for Ovestin® 1mg  cream restriction (PDF:166KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Oestrogel® Pump-Pack 0.06% gel restriction

Serious Shortage Protocol active for Oestrogel®  Pump-Pack 0.06% gel restriction (PDF:167KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Salazopyrin® 500mg tablets

Serious Shortage Protocol active for Salazopyrin® 500mg tablets (PDF:244KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Atorvastatin (Lipitor®) 20mg chewable tablets

Serious Shortage Protocol active for Atorvastatin (Lipitor®) 20mg chewable tablets (PDF:122KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Atorvastatin (Lipitor®) 10mg chewable tablets

Serious Shortage Protocol active for Atorvastatin (Lipitor®) 10mg chewable tablets (PDF:123KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Paracetamol 120mg and 240mg suppositories

Serious Shortage Protocol active for Paracetamol 120mg and 240mg suppositories (PDF:124KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Salazopyrin® 500mg EN tablets

Serious Shortage Protocol active for Salazopyrin® 500mg EN tablets (PDF:160KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Atorvastatin (Lipitor®) 20mg chewable tablets

Serious Shortage Protocol active for Atorvastatin (Lipitor®) 20mg chewable tablets (PDF:211KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Estradot® 75microgram patches

Serious Shortage Protocol active for Estradot®  75microgram patches (PDF:204KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Competact 15mg/850mg tablets

Serious Shortage Protocol active for Competact 15mg/850mg tablets (PDF:170KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Levothyroxine 12.5microgram tablets

Serious Shortage Protocol active for Levothyroxine 12.5microgram tablets (PDF:143KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Fluoxetine 40mg capsules

Serious Shortage Protocol active for Fluoxetine 40mg capsules (PDF:139KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Salazopyrin 500mg EN tablets

Serious Shortage Protocol active for Salazopyrin 500mg EN tablets (PDF:151KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Fluoxetine 30mg capsules

Serious Shortage Protocol active for Fluoxetine 30mg capsules (PDF:144KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Fluoxetine 40mg capsules

Serious Shortage Protocol active for Fluoxetine 40mg capsules (PDF:135KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Fluoxetine 10mg tablets

Serious Shortage Protocol active for Fluoxetine 10mg tablets (PDF:134KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Haloperidol (Serenace) 500 microgram (mcg) capsules

Serious Shortage Protocol active for Haloperidol  (Serenace) 500 microgram (mcg) capsules (PDF:107KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Fluoxetine 40mg capsules

Serious Shortage Protocol active for Fluoxetine 40mg capsules (PDF:131KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Fluoxetine 30mg capsules

Serious Shortage Protocol active for Fluoxetine 30mg capsules (PDF:124KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Fluoxetine 10mg capsules

Serious Shortage Protocol active for Fluoxetine 10mg capsules (PDF:151KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: • Rivastigmine 4.6mg/24hours transdermal patches • Rivastigmine 9.5mg/24hours tran

Co-codamol 30mg/500mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Co-codamol 30mg/500mg tablets. • Co-codamol 30mg/500mg tablets will be in limited supply from early February u

Class 4 Medicines Defect Notification: Quadrant Pharmaceuticals Limited, Vesomni 6 mg/0.4 mg modified release tablets

Quadrant Pharmaceuticals Limited have informed the MHRA that their parallel imported packs of Vesomni 6 mg/0.4 mg modified release tablets have been printed with the incorrect barcode/GTIN on the cart

Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2.5mg and 5mg Tablets

Sandoz Ltd. have informed the MHRA that the Patient Information Leaflet included in specified batches of Apixaban does not contain up‑to‑date information.

Regent Medical Limited / Mölnlycke Health Care, Hibiwash 500ml

Mölnlycke Health Care are recalling specific batches of Hibiwash due to microbial contamination at the manufacturing facility, following routine weekly microbiological monitoring.

Class 4 Medicines Defect Notification: Special Concept Development UK Limited, Baclofen 10mg Tablets

Special Concept Development UK Limited has informed the MHRA that the Patient Information Leaflet (PIL) for the batches listed in this notification do not contain the correct safety information.

Hameln Pharma Ltd, Clarithromycin 500 mg powder for concentrate for solution for infusion

Hameln Pharma Ltd is recalling certain batches of Clarithromycin 500 mg powder for concentrate for solution for infusion.

Activase Pharmaceuticals Limited, Prednisolone 5mg Soluble Tablets

Activase Pharmaceuticals Limited is recalling two batches of Prednisolone 5mg Soluble Tablets as a precautionary measure due to a limited number of reports of blister pockets becoming swollen over tim

Glenmark Pharmaceuticals Europe Limited, Fingolimod Glenmark 0.5 mg Hard Capsules

Glenmark Pharmaceuticals Europe Limited is recalling one batch after stability testing showed out-of-specification results. The batch is being recalled as a precautionary measure following test result

Mercury Pharmaceuticals Ltd, Paliperidone Mercury Pharma prolonged-release suspension for injection in pre-filled syringes

Mercury Pharmaceuticals Ltd is recalling remaining stock of paliperidone pre-filled syringes as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies cited during a recent insp

Class 4 Medicines Defect Notification: Viatris Products Ltd, Arixtra solution for injection, pre-filled syringes

Viatris has received reports of brown discolouration and blockage in the needle of pre-filled syringes of Arixtra. This quality defect is related to oxidation of the syringe needle.

Class 4 Medicines Defect Notification: Blumont Pharma Limited, Ocumont Eye Ointment 1% w/w

Blumont Pharma Limited is reporting to the MHRA regarding the absence of Braille on the outer carton of one batch of Ocumont Eye Ointment 1% w/w (POM). It was identified that the Braille information w

Syri Limited, T/A SyriMed, Baclofen 10mg/5ml Oral Solution

Syri Limited, T/A SyriMed is recalling batches of product as a precautionary measure due to crystallisation observed over time in the oral solution.

Accord Healthcare Ltd, Carmustine 100 mg Powder and Solvent for Concentrate for Solution for Infusion (1 vial 100mg powder, 1 vial of 3 mL solvent)

Accord Healthcare limited is recalling a single batch due to an out of specification test result.

Aspar Pharmaceuticals Ltd, Ibuprofen 200mg Tablets, Ibucalm 200mg tablets

Aspar Pharmaceuticals Ltd is recalling specific batches distributed in Aspar, Almus and Numark livery. The batches are being recalled as a precautionary measure following findings of foil perforations

Sterling Pharmaceuticals Ltd (specials manufacturer MS 32515), KidNaps (Melatonin) 1mg in 1ml Oral Solution

Sterling Pharmaceuticals Ltd and Veriton Pharma Ltd are recalling all batches of KidNaps (Melatonin) 1mg in 1ml Oral Solution due to out of specification stability results.

Norgine Limited, MOVICOL Ease Citrus Powder for oral solution 13.7 g

Norgine Limited is recalling one batch of product as a precautionary measure due to some units containing low amounts of active ingredients.

Crescent Pharma Limited, Ramipril 5mg capsules

Crescent Pharma Limited is recalling one batch of Ramipril 5 mg Capsules as a precautionary measure due to a potential error at the manufacturing site.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Bayer Plc, Various Products

Bayer Plc is recalling all stock of the products listed in this notification as a precautionary measure due to the identification of an impurity above the acceptable limit. The recall is at pharmacy a

Rokshaw Limited Trading as Curaleaf Laboratories, Curaleaf Oil [FS] 10mg/ml THC, 10mg/ml CBD (30ml)

Curaleaf Laboratories are recalling three batches of Curaleaf Oil [FS] 10mg/ml THC 10mg/ml CBD (30ml) due to low THC content.

Class 4 Medicines Defect Notification: Special Concept Development UK Limited, Baclofen 10mg Tablets

Special Concept Development UK Limited has informed the MHRA that the Patient Information Leaflet (PIL) for the batches listed in this notification do not contain the correct safety information.

Activase Pharmaceuticals Limited, Prednisolone 5mg Soluble Tablets

Activase Pharmaceuticals Limited is recalling two batches of Prednisolone 5mg Soluble Tablets as a precautionary measure due to a limited number of reports of blister pockets becoming swollen over tim

Hameln Pharma Ltd, Clarithromycin 500 mg powder for concentrate for solution for infusion

Hameln Pharma Ltd is recalling certain batches of Clarithromycin 500 mg powder for concentrate for solution for infusion.

Mercury Pharmaceuticals Ltd, Paliperidone Mercury Pharma prolonged-release suspension for injection in pre-filled syringes

Mercury Pharmaceuticals Ltd is recalling remaining stock of paliperidone pre-filled syringes as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies cited during a recent insp

Class 4 Medicines Defect Notification: Blumont Pharma Limited, Ocumont Eye Ointment 1% w/w

Blumont Pharma Limited is reporting to the MHRA regarding the absence of Braille on the outer carton of one batch of Ocumont Eye Ointment 1% w/w (POM). It was identified that the Braille information w

Glenmark Pharmaceuticals Europe Limited, Fingolimod Glenmark 0.5 mg Hard Capsules

Glenmark Pharmaceuticals Europe Limited is recalling one batch after stability testing showed out-of-specification results. The batch is being recalled as a precautionary measure following test result

Class 4 Medicines Defect Notification: Viatris Products Ltd, Arixtra solution for injection, pre-filled syringes

Viatris has received reports of brown discolouration and blockage in the needle of pre-filled syringes of Arixtra. This quality defect is related to oxidation of the syringe needle.

Accord Healthcare Ltd, Carmustine 100 mg Powder and Solvent for Concentrate for Solution for Infusion (1 vial 100mg powder, 1 vial of 3 mL solvent)

Accord Healthcare limited is recalling a single batch due to an out of specification test result.

Aspar Pharmaceuticals Ltd, Ibuprofen 200mg Tablets, Ibucalm 200mg tablets

Aspar Pharmaceuticals Ltd is recalling specific batches distributed in Aspar, Almus and Numark livery. The batches are being recalled as a precautionary measure following findings of foil perforations

Syri Limited, T/A SyriMed, Baclofen 10mg/5ml Oral Solution

Syri Limited, T/A SyriMed is recalling batches of product as a precautionary measure due to crystallisation observed over time in the oral solution.

Sterling Pharmaceuticals Ltd (specials manufacturer MS 32515), KidNaps (Melatonin) 1mg in 1ml Oral Solution

Sterling Pharmaceuticals Ltd and Veriton Pharma Ltd are recalling all batches of KidNaps (Melatonin) 1mg in 1ml Oral Solution due to out of specification stability results.

Norgine Limited, MOVICOL Ease Citrus Powder for oral solution 13.7 g

Norgine Limited is recalling one batch of product as a precautionary measure due to some units containing low amounts of active ingredients.

Bayer Plc, Various Products

Bayer Plc is recalling all stock of the products listed in this notification as a precautionary measure due to the identification of an impurity above the acceptable limit. The recall is at pharmacy a

Crescent Pharma Limited, Ramipril 5mg capsules

Crescent Pharma Limited is recalling one batch of Ramipril 5 mg Capsules as a precautionary measure due to a potential error at the manufacturing site.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Rokshaw Limited Trading as Curaleaf Laboratories, Curaleaf Oil [FS] 10mg/ml THC, 10mg/ml CBD (30ml)

Curaleaf Laboratories are recalling three batches of Curaleaf Oil [FS] 10mg/ml THC 10mg/ml CBD (30ml) due to low THC content.

Class 4 Medicines Defect Notification: Special Concept Development UK Limited, Baclofen 10mg Tablets

Special Concept Development UK Limited has informed the MHRA that the Patient Information Leaflet (PIL) for the batches listed in this notification do not contain the correct safety information.

Activase Pharmaceuticals Limited, Prednisolone 5mg Soluble Tablets

Lexon UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification is missing important updated safety information.

Hameln Pharma Ltd, Clarithromycin 500 mg powder for concentrate for solution for infusion

Hameln Pharma Ltd is recalling certain batches of Clarithromycin 500 mg powder for concentrate for solution for infusion.

Mercury Pharmaceuticals Ltd, Paliperidone Mercury Pharma prolonged-release suspension for injection in pre-filled syringes

Mercury Pharmaceuticals Ltd is recalling remaining stock of paliperidone pre-filled syringes as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies cited during a recent insp

Sterling Pharmaceuticals Ltd (specials manufacturer MS 32515), KidNaps (Melatonin) 1mg in 1ml Oral Solution

Sterling Pharmaceuticals Ltd and Veriton Pharma Ltd are recalling all batches of KidNaps (Melatonin) 1mg in 1ml Oral Solution due to out of specification stability results.

Rokshaw Limited Trading as Curaleaf Laboratories, Curaleaf Oil [FS] 10mg/ml THC, 10mg/ml CBD (30ml)

Glenmark Pharmaceuticals Europe Limited is recalling one batch after stability testing showed out-of-specification results. The batch is being recalled as a precautionary measure following test result

Letters and medicine recalls sent to healthcare professionals in April 2024

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices, and information about the publication of two recent Device Safety Information pages.

Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free and Co-trimoxazole 80mg/400mg/5ml oral suspension

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free and Co-trimoxazole 80mg/400mg/5ml oral suspension • C

Sodium valproate (Epilim Chronosphere® ) 100mg modified-release granules sachets sugar free

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Sodium valproate (Epilim Chronosphere®) 100mg modified-release granules sachets sugar free. • Sodium valproate

Propafenone (Arythmol® ) 150mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Propafenone (Arythmol®) 150mg tablets • Propafenone (Arythmol®) 150mg tablets are out of stock until early Apr

Expected resolution: April 2026

Nadolol 80mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Nadolol 80mg tablets • Nadolol 80mg tablets are out of stock from early March until early May 2024. • Alternat

Epilim® (sodium valproate) syrup 200mg/5ml

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Epilim® (sodium valproate) syrup 200mg/5ml • Epilim® 200mg/5ml syrup is out of stock from mid-March until w/c

Midazolam (Epistatus® ) 5mg/0.5ml oromucosal solution pre-filled oral syringes

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Midazolam (Epistatus®) 5mg/0.5ml oromucosal solution pre-filled oral syringes. • Midazolam (Epistatus®) 5mg/0.

Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials

This alert has been superseded by MSN/2024/028 (issued 06/03/2024) • Liaise with local pharmacy teams and place urgent orders for unlicensed imports of salbutamol nebuliser liquid – do not wait for su

Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable d

Levemir InnoLet® (insulin detemir) 100units/ml solution for injection 3ml pre-filled disposable devices

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Levemir InnoLet® (insulin detemir) 100units/ml solution for injection 3ml pre-filled disposable devices. • Lev

Phenobarbital 15mg tablets (Accord)

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Phenobarbital 15mg tablets (Accord) • Phenobarbital 15mg tablets (Accord) are out of stock with a resupply dat

Carbamazepine 100mg and 200mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Carbamazepine 100mg/5ml oral suspension sugar free (Accord) • Carbamazepine 100mg/5ml oral suspension sugar fr

Daktacort® (hydrocortisone 1% / miconazole 2%) cream

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Daktacort® (hydrocortisone 1% / miconazole 2%) cream • Daktacort® (hydrocortisone 1% / miconazole 2%) cream (3

Tegretol® (carbamazepine) 100mg/5ml liquid

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Tegretol® (carbamazepine) 100mg/5ml liquid • Tegretol® (carbamazepine) 100mg/5ml liquid is out of stock. Resup

Humulin® S (insulin soluble human) 100units/ml solution for injection 10ml vials

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Humulin® S (insulin soluble human) 100units/ml solution for injection 10ml vials. • Humulin® S (insulin solubl

Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials • There will be intermittent supplies of

Clarithromycin 125mg/5ml and 250mg/5ml oral suspensions

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Erythromycin 250mg gastro-resistant tablets • Erythromycin 250mg tablets are currently out of stock until w/c

Nortriptyline 10mg/5ml and 25mg/5ml oral solution sugar-free

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Nortriptyline 10mg/5ml and 25mg/5ml oral solution sugar-free • Nortriptyline 10mg/5ml oral solution sugar-free

Somatropin (NutropinAq® ) 10mg/2ml solution for injection cartridges Somatropin (Humatrope® ) 6mg, 12mg and 24mg powder and solvent for solution for injection cartridges

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Somatropin (NutropinAq®) 10mg/2ml solution for injection cartridges Somatropin (Humatrope®) 6mg, 12mg and 24mg

Erythromycin 250mg gastro-resistant tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Erythromycin 250mg gastro-resistant tablets • Erythromycin 250mg tablets are currently out of stock until w/c

Humalog® (insulin lispro) 100units/ml solution for injection 10ml vials

TO NOTE: This MSN is the one of two covering supply issues with insulin vials. MSN/2024/057 issued on 20/05/24 covered Humulin® S (insulin soluble human). This MSN (MSN/2024/072) covers Humalog® (insu

Flixotide® (fluticasone) 125micrograms/dose and 250micrograms/dose Evohaler®

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Flixotide® (fluticasone) 125micrograms/dose and 250micrograms/dose Evohaler® • Flixotide® (fluticasone) 125mic

Ipratropium bromide 250micrograms/1ml and 500micrograms/2ml nebuliser liquid unit dose vials

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Ipratropium bromide 250micrograms/1ml and 500micrograms/2ml nebuliser liquid unit dose vials. • Ipratropium br

Quetiapine 150mg, 200mg, 300mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Quetiapine 150mg, 200mg, 300mg tablets • There are limited supplies of quetiapine 150mg, 200mg and 300mg table

Carbamazepine 100mg/5ml oral suspension sugar free (Accord)

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Carbamazepine 100mg/5ml oral suspension sugar free (Accord) • Carbamazepine 100mg/5ml oral suspension sugar fr

Desmopressin (DDAVP®) 4 micrograms/1ml solution for injection ampoules

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Desmopressin (DDAVP®) 4 micrograms/1ml solution for injection ampoules • Desmopressin (DDAVP®) 4 micrograms/1m

Norethisterone (Noriday® ) 350microgram tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Norethisterone (Noriday®) 350microgram tablets • Norethisterone (Noriday®) 350microgram tablets will be out of

Nicorandil 10mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Nicorandil 10mg tablets. • There are limited supplies of nicorandil 10mg tablets until 30th September 2024. •

Torasemide 10mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Torasemide 10mg tablets • Torasemide 10mg tablets are in limited supply until March 2025. • Torasemide 5mg tab

Levobunolol (Betagan®) 0.5% eye drops 0.4ml unit dose preservative free

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Levobunolol (Betagan®) 0.5% eye drops 0.4ml unit dose preservative free. • Levobunolol (Betagan®) 0.5% eye dro

Coal tar extract (Neutrogena® T/Gel® Therapeutic) 2% shampoo

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Coal tar extract (Neutrogena® T/Gel® Therapeutic) 2% shampoo • Coal tar extract (Neutrogena® T/Gel® Therapeuti

Cefalexin 125mg/5ml and 250mg/5ml oral suspensions, sugar free

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Cefalexin 125mg/5ml and 250mg/5ml oral suspensions, sugar free • Cefalexin 125mg/5ml and 250mg/5ml oral suspen

Triptorelin acetate (Gonapeptyl® Depot) 3.75mg powder and solvent for suspension for injection pre-filled syringes

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Triptorelin acetate (Gonapeptyl® Depot) 3.75mg powder and solvent for suspension for injection pre-filled syri

Galantamine 8mg, 16mg and 24mg modified-release capsules

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Galantamine 8mg, 16mg and 24mg modified-release capsules. • Galantamine 8mg modified release capsules are in l

Lidocaine (Xylocaine® ) 10mg/dose spray sugar free

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Lidocaine (Xylocaine®) 10mg/dose spray sugar free. • Lidocaine (Xylocaine®) 10mg/dose spray sugar free is out

Tolterodine 2mg and 4mg modified-release capsules

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Tolterodine 2mg and 4mg modified-release capsules • Tolterodine 2mg and 4mg modified-release (MR) capsules are

Abidec® Multivitamin drops

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following product: • Abidec® Multivitamin drops • Abidec® Multivitamin drops are out of stock until fu

Vials of Humulin® I, Humulin® S, Humulin® M3, and Humalog® Mix25 are being discontinued.

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: • Humulin® I (insulin isophane human) 100units/ml suspension for injection 10ml vi

Expected resolution: April 2026

Isosorbide mononitrate 10mg tablets (immediate-release)

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following product: • Isosorbide mononitrate 10mg tablets (immediate-release) • Isosorbide mononitrate

Estradiol (Progynova® TS) 50micrograms/24hours and 100micrograms/24hours transdermal patches

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following product: • Estradiol (Progynova® TS) 50micrograms/24hours and 100micrograms/24hours transder

Updated Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3ml pre-filled pens and Levemir® Penfill 100units/ml solution for injection 3ml cartridges

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: • Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3ml pre-f

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

Repaglinide 500microgram,1mg and 2mg tablets

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following product: • Repaglinide 500microgram,1mg and 2mg tablets • Repaglinide 500microgram and 1mg t

Exenatide (Bydureon® BCise® ) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: • Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injecti

Dalivit® Oral Drops

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: • Dalivit® Oral Drops • Dalivit® Oral Drops are out of stock until further notice.

Mometasone (Asmanex Twisthaler®) 200micrograms/dose dry powder and 400micrograms/dose dry powder inhalers

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: • Mometasone (Asmanex Twisthaler®) 200micrograms/dose dry powder and 400micrograms

Amiodarone 100mg and 200mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Amiodarone 100mg and 200mg tablets • Amiodarone 100mg and 200mg tablets are in limited supply until w/c 17 Nov

Nifedipine (Fortipine® LA) 40mg modified-release tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Nifedipine (Fortipine® LA) 40mg modified-release tablets. • Nifedipine (Fortipine® LA) 40mg modified-release t

Fiasp® FlexTouch® (insulin aspart) 100units/ml solution for injection 3ml pre-filled pens

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Fiasp® FlexTouch® (insulin aspart) 100units/ml solution for injection 3ml pre-filled pens. • Fiasp® FlexTouch®

Tresiba® (insulin degludec) FlexTouch® 100units/ml solution for injection 3ml prefilled pens

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Tresiba® (insulin degludec) FlexTouch® 100units/ml solution for injection 3ml prefilled pens. • Tresiba® FlexT

Genotropin® (somatropin) 5.3 mg and 12 mg powder and solvent for solution for injection

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Genotropin® (somatropin) 5.3 mg and 12 mg powder and solvent for solution for injection • The reusable Pen dev

Buprenorphine/naloxone (Suboxone® ) 2mg/500microgram and 8mg/2mg sublingual tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Buprenorphine/naloxone (Suboxone®) 2mg/500microgram and 8mg/2mg sublingual tablets. • Buprenorphine/naloxone (

Class 4 Medicines Defect Notification: Baxter Healthcare Corporation, Onkotrone Injection 2 mg/ml concentrate for solution for infusion

Baxter Healthcare Corporation have informed the MHRA that the Patient Information Leaflet (PIL) packed in specified batches does not contain up to date information relating to the duration of contrace

Class 4 Medicines Defect Notification: Lexon UK Ltd, Moclobemide 150mg tablets

Lexon UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification is missing important updated safety information.

Class 4 Medicines Defect Notification: Flamingo Pharma UK Ltd, Amitriptyline Hydrochloride 10mg, 25mg, 50mg Tablets

Flamingo Pharma UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information.

Class 4 Medicines Defect Notification: Rayner Pharmaceuticals Limited, Dropodex 0.1% w/v Eye Drops, solution

Rayner Pharmaceuticals limited have informed the MHRA that the batches listed in this notification do not include the concentration of phosphates in the product information.

Class 4 Medicines Defect Notification: Lexon UK Ltd, Moclobemide 150mg tablets

Lexon UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification is missing important updated safety information.

Class 4 Medicines Defect Notification: Flamingo Pharma UK Ltd, Amitriptyline Hydrochloride 10mg, 25mg, 50mg Tablets

Flamingo Pharma UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information.

Class 4 Medicines Defect Notification: Rayner Pharmaceuticals Limited, Dropodex 0.1% w/v Eye Drops, solution

Rayner Pharmaceuticals limited have informed the MHRA that the batches listed in this notification do not include the concentration of phosphates in the product information.

Letters and medicine recalls sent to healthcare professionals in February 2024

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.

Letters and medicine recalls sent to healthcare professionals in January 2024

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.

Letters and medicine recalls sent to healthcare professionals in March 2024

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.

Letters and medicine recalls sent to healthcare professionals in May 2024

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.

Letters and medicine recalls sent to healthcare professionals in June 2024

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.

Letters and medicine recalls sent to healthcare professionals in August 2024

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.

Letters and medicine recalls sent to healthcare professionals in July 2024

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.

Letters and medicine recalls sent to healthcare professionals in October 2024

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.

Letters and medicine recalls sent to healthcare professionals in September 2024

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.

Letters and medicine recalls sent to healthcare professionals in December 2024

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices. 

Letters and medicine recalls sent to healthcare professionals in November 2024

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.

Letters and medicine recalls sent to healthcare professionals in January 2025

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices. 

Lisdexamfetamine (Elvanse®) capsules

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Lisdexamfetamine (Elvanse®) capsules. • There will be intermittent supply of all strengths of lisdexamfetamine

Lisdexamfetamine (Elvanse®) capsules

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Lisdexamfetamine (Elvanse®) capsules • All strengths of Elvanse® capsules are now available and an improved le

Creon® Micro Pancreatin 60.12mg gastro-resistant granules

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Creon® Micro Pancreatin 60.12mg gastro-resistant granules • Creon® Micro Pancreatin 60.12mg gastro-resistant g

Trandate® (labetalol) 50mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Trandate® (labetalol) 50mg tablets • Trandate® (labetalol) 50mg tablets will be discontinued from July 2025. •

Sodium fusidate (Fucidin® ) 250mg tablets and fusidic acid (Fucidin® ) 250mg/5ml oral suspension

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Sodium fusidate (Fucidin®) 250mg tablets and fusidic acid (Fucidin®) 250mg/5ml oral suspension • Sodium fusida

Camellia sinensis extract (Catephen® ) 10% ointment Fluorouracil (Efudix® ) 5% cream Imiquimod (Aldara® 5% and Zyclara® 3.75%) cream 250mg sachets

Update (03/02/2025): Updates to communication (MSN/2024/109) issued 26 November 2024 in bold • Limited supply of alternative products (see Supporting Information). • Unlicensed supplies may be sourced

Quetiapine 50mg, 150mg, 200mg, 300mg and 400mg modified-release tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Quetiapine 50mg, 150mg, 200mg, 300mg and 400mg modified-release tablets • There are supply constraints affecti

Levofloxacin 250mg and 500mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Levofloxacin 250mg and 500mg tablets • Levofloxacin 250mg tablets are in limited supply until late April 2025

Discontinuation of Subutex® and Suboxone® tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for: Flixotide® (fluticasone) 50 micrograms/dose Evohaler • Flixotide® (fluticasone) 50 micrograms/dose Evohaler i

Discontinuation of Subutex® and Suboxone® tablets

Update 15/01/2026: DHSC has issued a Medicine supply Notification for Buprenorphine/naloxone (Suboxone® ) 2mg/500microgram and 8mg/2mg sublingual tablets.

SSP61 - Creon® 25000 gastro-resistant capsules further extended

In response to a significant ongoing disruption to the supply of Creon® 25000 gastro-resistant capsules , a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care

Expiry of SSP084 Adipine® XL 30mg MR tablets and SSP085 Adipine® XL 60mg MR tablets

Serious Shortage Protocol active for Adipine® XL 30mg MR tablets (PDF:199KB). Pharmacists may supply alternatives without GP referral.

⚠️ Resolution date passed — supply status unconfirmed. Check with your pharmacist.

SSP60 - Creon® 10000 gastro-resistant capsules further extended

In response to a significant ongoing disruption to the supply of Creon® 10000 gastro-resistant capsules, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (